Healthcare Sales & Marketing Network News: Hexvix

Searching News Database: Hexvix

HSMN NewsFeed - 16 May 2018
Photocure Announces Blue Light Cystoscopy with Cysview(R) Now Available for Surveillance of Bladder Cancer
Devices Diagnostics Oncology Product Launch

HSMN NewsFeed - 16 Feb 2018
Photocure Announces U.S. FDA Approval of New Indication for Blue Light Cystoscopy with Cysview(R)
Devices Oncology FDA

HSMN NewsFeed - 2 May 2016
Enhanced Cystoscopy including Blue Light Cystoscopy with Cysview(R)/Hexvix(R) is Recommended in the New AUA/SUO Bladder Cancer Guideline
Biopharmaceuticals Diagnostics Urology Oncology

HSMN NewsFeed - 15 Mar 2011
Breakthrough Light-Activated Drug-Device to be Investigated for Treatment of HPV* and Cervical Pre-cancer
Biopharmaceuticals Devices Oncology

HSMN NewsFeed - 1 Jun 2010
Cysview(TM) (Hexaminolevulinate HCL) Approved by the FDA for Cystoscopic Detection of Papillary Bladder Cancer
Diagnostics Oncology FDA

HSMN NewsFeed - 31 Dec 2009
Photocure Received Positive Response From FDA on the New Drug Application (NDA) for Hexvix(R) for Detection of Bladder Cancer
Biopharmaceuticals Diagnostics Oncology FDA

HSMN NewsFeed - 31 May 2006
DUSA Pharmaceuticals And PhotoCure ASA Settle Patent Disputes
Biopharmaceuticals Litigation

HSMN NewsFeed - 9 Jan 2006
GE Healthcare and PhotoCure Announce Licensing Partnership for the Optical Imaging of Bladder Cancer
Biopharmaceuticals Licensing Diagnostics

Return to NewsFeed

FindReps - Find Great Medical Independent Sales Reps without recruiter fees.

FindReps - available on the Apple App Store for iPhone and iPad.